News - EASL Recommendations on Treatment of hepatitis C 2016

The European Association for the Study of the Liver (EASL) issues Recommendations on Treatment of Hepatitits C 2016:

The recommendations have been prepared by a panel of experts chosen by the EASL Governing Board and were approved by the EASL Governing Board.
They have been based as far as possible on evidence from existing publications and presentations at international meetings, and, if evidence was unavailable, the experts’ personal experiences and opinion.

Tags: 

News - WHO E-learning course on Vaccine Safety Basics

The WHO e-learning course on vaccine safety basics intends to establish a shared understanding among professionals whose work is linked to vaccine safety issues.
The course addresses the following issues:

  • oringin and nature of advers events follwing immunzation; 
  • promoting good communication practices in handling risks and crises situations

The course is destined to nurses, midwives, community health workers, as well as pharmacists medical doctors and programme or technical officers.

More information:

Tags: 

News - European action plan on Viral Hepatitis adopted by the 66th Session of the WHO Regional Committee

At the Sixty-sixth Session of the WHO Regional Committee for Europe (RC66), the 53 Members States of the WHO European Region have unanimously adopted the first ever "Action plan for the health sector response to Viral Hepatitis in the WHO European Region”, and endorsed the resolution EUR/RC66/R10 to adopt the action plan:

Many Member States and WHO partners have voiced their support through strong statements of support at RC66.

Tags: 

News - International Viral Hepatitis Elimination Meeting 2016

The 3rd International Meeting on Elimination of Viral Hepatitis 2016 will be held from 2 - 3 December 2016 at the West Indisch Huis, Amsterdam, The Netherlands.

The field of viral hepatitis treatment is undergoing major changes and is on the verge of a paradigm shift. The introduction of Direct Acting Antivirals are providing great hopes for:

  • decreasing the burden of disease,
  • simplifying treatment and, ultimately,
  • the elimination of viral Hepatitis.
Tags: 

News - ECDC highlights the goal of eliminating viral hepatitis as a public health by 2030 on World Hepatitis Day

On the occasion of World Hepatitis Day, ECDC launches 2014 surveillance data on hepatitis B and C in Europe.

The data show a greater disease burden for hepatitis C compared with hepatitis B across Europe: numbers and notification rates for HCV are nearly twice as high as those of hepatitis B.

New ECDC technical outputs:

• Annual epidemiological report: Surveillance data on Hepatitis B 
• Annual epidemiological report: Surveillance data on hepatitis C
• Epidemiological assessment of Hepatitis B and C among migrants

Tags: 

News - ELPA launches Hep-CORE study in advance of World Hepatitis Day

ELPA Launches Hep-CORE Study in Advance of World Hepatitis Day:

Preliminary data from patient groups raise concerns about responses to HBV and HCV in Europe

Tags: 

News - First European hepatitis Awareness week - 25-29 July 2016

European Hepatitis Awareness week - 25-29 July 2016

The Hepatits B and C Public Policy Association launches the first European Hepatitis Awareness week:

Tags: 

News - NoHep

NOhep, a global movement to eliminate viral hepatitis, will be launched on WHD2016 to bring people together and provide a platform for people to speak out, be engaged and take action to ensure global commitments are met and viral hepatitis is eliminated by 2030.

 

Tags: 

News - 28 July 2016 World Hepatitis Day

28 July is World Hepatitis Day. The theme for 2016 is ELIMINATION:

  • Events take place across the world to celebrate World Hepatitis Day - find out what is happening near you on the map of impact;
  • Campaign materials can be downloaded here.

 

 

Tags: 

News - Preventing Perinatal Hepatitis B virus Transmission

The Hepatitis Birth Dose Guide developed by the Expanded Programme on Immunization (EPI) of the WHO’s Department of Immunization, Vaccines and Biologicals has been published.

The guide includes:

  • an overview of WHO recommendations, best practices, technical justification and strategic approaches relating to providing hepatitis B birth dose to newborns;
  • operational requirements for introducing a vaccination that should be delivered as soon after birth as possible, preferably within 24 hours (and explicitly mentions false contraindications);
  • information for policy discussions and operational strategies for the introduction of hepatitis B birth dose vaccination into a national immunization programme.

 

Tags: 

Pages